<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119272">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01550198</url>
  </required_header>
  <id_info>
    <org_study_id>Edscini Study 1.0</org_study_id>
    <nct_id>NCT01550198</nct_id>
  </id_info>
  <brief_title>Early Detection of Neonatal Shock</brief_title>
  <acronym>Edscini</acronym>
  <official_title>Early Detection of Shock in Critically Ill Newborn Infants. The Impact of Advanced Hemodynamic Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the hypothesis that advanced hemodynamic monitoring
      results in an earlier detection of circulatory failure in newborn infants
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output assessed by transpulmonary ultrasound dilution and simultaneously clinically estimated cardiac output</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Impact of Advanced Hemodynamic Monitoring</condition>
  <arm_group>
    <arm_group_label>Newborns</arm_group_label>
    <description>Critically ill newborns admitted to level III neonatal intensive care unit of a university hospital, who will be monitored using transpulmonary ultrasound dilution (&quot;advanced hemodynamic monitoring&quot;)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Advanced hemodynamic monitoring</intervention_name>
    <description>Comprehensive advanced hemodynamic monitoring</description>
    <arm_group_label>Newborns</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates admitted to a neonatal intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birth weight &gt;700 grams

          -  Arterial catheter in place

          -  Central venous catheter in place

          -  Informed consent from parents/legal representatives

        Exclusion Criteria:

          -  Life-threatening congenital defects

          -  Congenital heart defects, except patent ductus arteriosus and patent foramen ovale
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Willem de Boode, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Willem de Boode, MD PhD</last_name>
    <phone>+31 24 3614430</phone>
    <email>willem.deboode@radboudumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre, Department of Neonatology</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Willem de Boode, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 12, 2016</lastchanged_date>
  <firstreceived_date>March 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>newborn</keyword>
  <keyword>shock</keyword>
  <keyword>hemodynamics</keyword>
  <keyword>cardiac output</keyword>
  <keyword>blood pressure</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
